Product
Double-blind Placebo-controlled
1 clinical trial
1 indication
Indication
PsoriasisClinical trial
A Multicenter, Randomized, Double Blind, Placebo Controlled Clinical Study to Assess the Efficacy and Safety of Tildrakizumab in the Treatment of Moderate to Severe Plaque Psoriasis of the ScalpStatus: Completed, Estimated PCD: 2022-02-17